Immunohistochemistry in BC patient samples further revealed a significant correlation between fascin expression and higher levels of the standard proliferation marker (Ki-67) and nuclear SKP2, alongside reduced nuclear p27. This evidence concerns the gene FSCN1 and breast cancer.